LYSSAVIRUS ANTIGEN CONSTRUCTS

Nucleic acid based vaccine constructs encoding Lyssaviral antigens are useful in preventing and treating diseases. Self-amplifying RNA molecules encoding Lyssaviral antigens provide potent and long-lasting immunity. La présente invention concerne des constructions de vaccin à base d'acides nucl...

Full description

Saved in:
Bibliographic Details
Main Authors HASHEY, Kathryn, YU, Dong, SAMSA, Marcelo, JALAH, Rashmi, MALYALA, Padma, SLACK, Olga, STOKES, Alan
Format Patent
LanguageEnglish
French
Published 24.01.2019
Subjects
BEER
BIOCHEMISTRY
CHEMISTRY
COMPOSITIONS THEREOF
CULTURE MEDIA
ENZYMOLOGY
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
MICROBIOLOGY
MICROORGANISMS OR ENZYMES
MUTATION OR GENETIC ENGINEERING
ORGANIC CHEMISTRY
PEPTIDES
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS
SPIRITS
VINEGAR
WINE
Online AccessGet full text

Cover

More Information
Summary:Nucleic acid based vaccine constructs encoding Lyssaviral antigens are useful in preventing and treating diseases. Self-amplifying RNA molecules encoding Lyssaviral antigens provide potent and long-lasting immunity. La présente invention concerne des constructions de vaccin à base d'acides nucléiques codant pour des antigènes de lyssavirus qui sont utiles dans le cadre de la prévention et du traitement de maladies. Des molécules d'ARN à auto-amplification codant pour des antigènes de lyssavirus confèrent une immunité puissante et durable.
Bibliography:Application Number: WO2018IB55258